MaaT Pharma announces €10 million fundraising and pursues the development of the first worldwide autologous microbiotherapy solution. The investment transaction, led by CM-CIC Innovation with Seventure Partners, the pharmaceutical firm Biocodex and the Inra, will allow the start-up to enter the clinical phase. MaaT Pharma is developing a medicine providing treatment for dysbiosis following major treatment against cancer and certain infections.  Read more